SCHEMBL4008784

SCHEMBL4008784

Cc1c(NC(=O)c2ccccc2C(C)(C)C)cccc1-c1cn(C)c(=O)c(Nc2ccc(O)cc2)n1

nearest known ligand 0.58

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BTK Q06187 20/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5241328 0.89 BTK (0.54) BTK
SCHEMBL1070603 0.86 BTK (0.76) BTK
SCHEMBL28414908 0.86 BTK (0.81) BTK
SCHEMBL4005794 0.86 BTK (0.56) BTK
SCHEMBL5278595 0.85 BTK (0.56) BTK
SCHEMBL5243047 0.85 BTK (0.67) BTK
SCHEMBL5240845 0.84 BTK (0.53) BTK
SCHEMBL27737943 0.84 BTK (0.54) BTK
SCHEMBL4006157 0.81 BTK (0.71) BTK
SCHEMBL12637670 0.80 BTK (0.75) BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2068849-A2 KINASE INHIBITORS, AND METHODS OF USING AND IDENTIFYING KINASE INHIBITORS CGI Pharmaceuticals, Inc. (US) 2009-06-17 EP disclosed
WO-2008033858-A2 KINASE INHIBITORS, AND METHODS OF USING AND IDENTIFYING KINASE INHIBITORS CGI PHARMACEUTICALS, INC. (US) 2008-03-20 WO disclosed
EP-1863766-A2 CERTAIN SUBSTITUTED AMIDES, METHOD OF MAKING, AND METHOD OF USE THEREOF CGI Pharmaceuticals, Inc. (US) 2007-12-12 EP disclosed
WO-2006099075-A2 CERTAIN SUBSTITUTED AMIDES, METHOD OF MAKING, AND METHOD OF USE THEREOF CGI PHARMACEUTICALS, INC. (US) 2006-09-21 WO disclosed